Salut, Covid-19, Vacunes
The Japanese biopharmacy company Takeda reached in October an agreement with Moderna and the Japanese Ministry of Health, Labour and Welfare to distribute 50 million doses during the first half of 2021 under the TAK-919 name. On 21 May 2021, Takeda announced the approval of the formula by the Japanese Government, and informed that the distribution would immediately start.
Read all the information about Moderna’s vaccine here.
Aquest article és part del projecte "Les Mentides Amenacen la Salut", el primer portal de fact-checking de rumors sobre la covid-19 de Catalunya.